Biomedical, Clinical & Life Sciences

Susan G. Komen Brinker Awards for Scientific Distinction 2025

No Applicants // Limit: 3* // Tickets Available: 3


*The University of Arizona Cancer Center (UACC) can nominate up to three applicants (one per category) for the Susan G. Komen’s Brinker Awards for Scientific Distinction 2025 which recognizes pioneering work in breast cancer research and treatment. 

For more information please contact: UACC-PreAward.

Award Categories (Limit 1 Each) 

  • The Brinker Award for Scientific Distinction in Basic Science will be presented to a basic science and/or translational researcher whose scientific discoveries or novel technologies have substantively impacted our understanding of the basic biology and intrinsic molecular processes driving breast cancer to improve breast cancer care.
  • The Brinker Award for Scientific Distinction in Clinical Research will be presented to a clinical researcher who has advanced new approaches for prevention, detection, diagnosis and treatment that have paved the way for new clinical and therapeutic applications and/or practice changing, patient-focused care for breast cancer.
  • The Brinker Award for Scientific Distinction in Population Science will be presented to a researcher who has made pivotal advances in implementing science, cancer care delivery, health services research, epidemiology and/or developed innovative evidence-based interventions to enhance breast cancer outcomes.
Funding Type
Internal Deadline
External Deadline
5/12/2025
Solicitation Type

V Foundation Pediatric Cancer Research Grant 2025

Limit: 2* // Tickets Available: 1

K. Huntoon (Neurosurgery)- V Scholar

The University of Arizona Cancer Center (UACC) can nominate can nominate up to two proposals: one Translational OR V Scholar nominee and one All-Star nominee (if eligible) for the V Foundation Pediatric Cancer Research Grant 2025.

For more information please contact: UACC-PreAward.

Eligibility

Nominee must meet all of the following criteria by the nomination due date:

  • Nominated by their Cancer Center Director or similar high ranking research official.
  • Employed at a non-profit research institution (e.g., 501c3, Section 170).
  • Either a US Citizen or a permanent legal resident in the US
  • See additional criteria for each mechanism listed in corresponding RFA within the Supporting Documents section above.
Funding Type
Internal Deadline
External Deadline
5/7/2025
Solicitation Type

Brain Research Foundation 2026 Scientific Innovations Award

Limit: 1 // Tickets Available: 0

J. Streicher (Pharmacology)

Objective
The program's objective is to support projects that may be too innovative and speculative for traditional funding sources but still have a high likelihood of producing important findings. It is expected that investigations supported by these grants will yield high-impact findings and result in major grant applications and funding as well as significant publications in high-impact journals.

Eligibility
The nominated candidate must be a full-time associate professor or full professor at a US academic institution working in the area of studies of brain function in health and disease. Current major NIH or other peer-reviewed funding is preferred but evidence of such funding in the past three years is essential. Studies should be related to either normal human brain development or specifically identified disease states. This includes molecular and clinical neuroscience as well as studies of neural, sensory, motor, cognitive, behavioral and emotional functioning in health and disease. The grant proposal must detail a new research project that is not funded by other sources. This grant is not to be used as bridge funding. 

Investigators at institutions that are affiliated with a medical school or university are eligible to apply only through the institution where they hold a full-time faculty position. 

Scientists that have previously received a BRF Scientific Innovations Award may not receive the award for a second time until five years has elapsed since the beginning date of the prior award. Grant requirements from all previous awards must be met.  Only one PI may apply per application. (Applicant may include the name of a Co-PI within or from another institution, but no additional supporting materials for the Co-PI are required, including biosketch, current grants, abstracts, etc.) 

Funding Type
Internal Deadline
External Deadline
6/3/2025
Solicitation Type

NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Required) - June 2025 Deadline

Limit: 4* (see below) // Tickets Available: 4

Cancer Data Science // Limit: 1 // Tickets Available: 1

Cancer Control Science // Limit: 1 // Tickets Available: 1

Molecular Precision/Cancer Prevention // Limit: 1 // Tickets Available: 1 

Other Cancer Research // Limit: 1 // Tickets Available: 1

Number of Applications
Applicant organizations may submit more than one application, provided that each application is scientifically distinct, and each is from a different candidate.

NIH will not accept duplicate or highly overlapping applications under review at the same time per NIH Grants Policy Statement Section 2.3.7.4 Submission of Resubmission Application. An individual may not have two or more competing NIH career development applications pending review concurrently. In addition, NIH will not accept:

  • A new (A0) application that is submitted before issuance of the summary statement from the review of an overlapping new (A0) or resubmission (A1) application.
  • A resubmission (A1) application that is submitted before issuance of the summary statement from the review of the previous new (A0) application.
  • An application that has substantial overlap with another application pending appeal of initial peer review. (See NIH Grants Policy Statement 2.3.9.4 Similar, Essentially Identical, or Identical Applications).

Each eligible institution (defined as having a unique UEI number or NIH IPF number) may submit up to a combined total of four applications (one in Cancer Data Science, one in Cancer Control Science, one in Molecular/Precision Cancer Prevention, and one in Other Cancer Research) to any companion NOFO or any combination of companion NOFOs (PAR-23-286, PAR-23-287, and/or PAR-23-288).

Scientific Areas

  • (A) Cancer Data Science: For the purposes of this K99/R00 award, cancer data science is defined as an interdisciplinary field of inquiry in which quantitative and analytical approaches, processes, and systems are both developed and used to extract knowledge and insights from increasingly large and/or complex sets of data. This includes cancer-focused data integration and visualization, systems biology, artificial intelligence, machine learning, informatics, genomics, precision oncology, and developing analytics for epidemiological or biostatistical studies.
  • (B) Cancer Control Science: For the purposes of this K99/R00 award, cancer control science is defined as basic and applied research in the behavioral, social, and population sciences to create or enhance interventions that, independently or in combination with biomedical approaches reduce cancer risk, incidence, morbidity, and mortality, and improve quality of life. This includes research in epidemiology, behavioral sciences, health services, surveillance, cancer survivorship, and healthcare policy.
  • (C) Molecular/Precision Cancer Prevention: For the purpose of this K99/R00 award, early translational research in cancer prevention is defined as basic research to understand mechanisms of cancer formation, development and progression of cancer precursors, and to translate basic biological knowledge into novel human interventions and human-centered adaption of current interventions with the potential to reduce cancer risk, incidence, and mortality, and improve quality of life. This includes but is not limited to research in molecular and systems biology, diagnostics, vaccine and drug development, pharmacology, and biomedical engineering.
  • (D) Other Cancer Research: For the purposes of this K99/R00 award, "Other Cancer Research" includes all scientific fields supported by the NCI that are not included in (A), (B) or (C). Applicants proposing research in (D) "Other Cancer Research" may apply only if it is reasonable to expect their candidates to transition to independence with an abbreviated period of mentored research training beyond their original doctoral degrees."


 

Funding Type
Internal Deadline
External Deadline
6/16/2025
Solicitation Type

HRSA-25-082: Living Organ Donation Reimbursement Program (LODRP)

No Applicants // Limit: 1 // Tickets Available: 1

Application Limits:
You may not submit more than one application. If you submit more than one application, we will only accept the last on-time submission.

Purpose:
The purpose of this program is to reduce financial disincentives to living organ donation by providing means-tested reimbursement of lost wages, transportation, meals, and dependent care (child care and elder care) expenses and other qualified expenses to living organ donors.

Funding Type
Internal Deadline
External Deadline
4/18/2025

Nutrition Obesity Research Centers (P30 Clinical Trial Optional)

No applicants // Limit: 1 // Tickets Available: 1

Eligibility
Only one application per institution (normally identified by having a unique DUNS number or NIH IPF number) is allowed.

Purpose
This Notice of Funding Opportunity (NOFO) invites applications from institutions/organizations that propose to establish core centers that are part of an integrated and existing program of nutrition and/or obesity research. The Nutrition Obesity Research Centers (NORC) program is designed to support and enhance the national research effort in nutrition and obesity. NORCs support three primary research-related activities: Research Core services, a Pilot and Feasibility (P and F) program, and an Enrichment program. All activities pursued by Nutrition Obesity Research Centers are designed to enhance the efficiency, productivity, effectiveness, and multidisciplinary nature of research in nutrition and obesity.

Funding Type
Internal Deadline
External Deadline
6/10/2025

The Conservation, Food & Health Foundation - Support for Programs in Developing World (2025 - Grant Round 2)

Limit: 1 // Tickets Available: 0

M. Baro (Anthropology) 

Eligibility
In fairness to other organizations seeking support, we ask that organizations submit only one concept application per round of funding.

Description
The Conservation, Food and Health Foundation seeks to protect the environment, improve food production, and promote public health in Africa, Asia, the Caribbean, Latin America, and the Middle East. 

For all fields of interest, please see the funding opportunity webpage.



 

Funding Type
Internal Deadline
External Deadline
6/15/2025

PhRMA Foundation: 2025 Drug Discovery Postdoctoral Fellowship

No Applicants // Limit: 1 postdoctoral applicant per lab

The PhRMA Foundation Postdoctoral Fellowship in Drug Discovery supports individuals (U.S. and non-U.S. citizens) engaged in a multidisciplinary, collaborative research training program at an accredited U.S. university that will extend their credentials in drug discovery research.

Eligibility
Only one postdoctoral applicant per lab may apply for this award. If multiple applicants apply, they will automatically be ineligible. Potential applicants and their thesis advisors and/or lab managers should decide who should apply.

For full eligibility criteria, please see the Drug Discovery Postdoctoral Fellowship webpage.

Funding Type
Internal Deadline
External Deadline
4/15/2025
Solicitation Type

PhRMA Foundation: 2025 Drug Delivery Postdoctoral Fellowship

No Applicants // Limit: 1 postdoctoral applicant per lab

The PhRMA Foundation Postdoctoral Fellowship in Drug Delivery supports individuals (U.S. and non-U.S. citizens) engaged in a multidisciplinary, collaborative research training program at an accredited U.S. university that will extend their credentials in drug delivery research, including basic pharmaceutics, biopharmaceutics, pharmaceutical technology, pharmaceutical biotechnology, or biomedical engineering.

Eligibility
Only one postdoctoral applicant per lab may apply for this award. If multiple applicants apply, they will automatically be ineligible. Potential applicants and their thesis advisors and/or lab managers should decide who should apply.

For full eligibility criteria, please see the Drug Delivery Postdoctoral Fellowship webpage.

Funding Type
Internal Deadline
External Deadline
4/15/2025
Solicitation Type

PhRMA Foundation: 2025 Drug Delivery Predoctoral Fellowship

Limit: 1 predoctoral applicant per lab

M.P. Resmi (Ganesh Lab, Department of Molecular Medicine) 

The PhRMA Foundation Predoctoral Fellowship in Drug Delivery provides support for promising students (U.S. and non-U.S. citizens) in advanced stages of training and thesis research in drug delivery research, including basic pharmaceutics, biopharmaceutics, pharmaceutical technology, pharmaceutical biotechnology, or biomedical engineering.

Eligibility
Only one predoctoral applicant per lab may apply for this award. If multiple applicants apply, they will automatically be ineligible. Potential applicants and their thesis advisors and/or lab managers should decide who should apply.

For full eligibility criteria, please see the Drug Delivery Predoctoral Fellows webpage.

Funding Type
Internal Deadline
External Deadline
4/15/2025
Solicitation Type